De La Rosa Abel 4
4 · Virios Therapeutics, Inc. · Filed Jun 30, 2022
Insider Transaction Report
Form 4
De La Rosa Abel
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-23+5,250→ 5,250 totalExercise: $4.23Exp: 2032-06-23→ Common Stock (5,250 underlying)
Footnotes (1)
- [F1]The stock option will vest 100% on June 23, 2023, one year following the grant date.